Report summary

Notifier

Name of person with notification obligation

Lars Öhman

Reason for notification

Closely associated

Person discharging managerial responsibilities

Lars Öhman

Position

Chairman of the Board of Directors

Initial notification

Yes

Amendment

Details of amendment

Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor

Name of issuer

Lipigon Pharmaceuticals AB

Issuer´s LEI code

549300XPO40YR12SLY87

Details of transaction

Type of financial instrument	Financial instrument	ISIN code	Nature of transaction	Linked to the exercise of a share option programme	Volume	Unit	Price per unit	Currency code	Transaction date	Place of the transaction
Subcription warrant	Lipigon Pharmaceuticals AB TO2	SE0019914094	Exercise decrease		343,200	Quantity	0.30	SEK	14/12/2023	Outside a trading venue
Share	Lipigon Pharmaceuticals AB	SE0015382072	Exercise increase		343,200	Quantity	0.30	SEK	14/12/2023	Outside a trading venue

Aggregation

Financial instrument	ISIN code	Nature of transaction	Transaction date	Place of the transaction	Volume	Weighted average price
Lipigon Pharmaceuticals AB TO2	SE0019914094	Exercise decrease	14/12/2023	Outside a trading venue	343,200 (Quantity)	0.30 SEK
Lipigon Pharmaceuticals AB	SE0015382072	Exercise increase	14/12/2023	Outside a trading venue	343,200 (Quantity)	0.30 SEK

<< Back